The Pharmaceutical Industry Global Analysis

Economic: Globalization of the pharmaceutical industry is an exciting opportunity to have research and development done at cheaper prices in other countries. However, this could be a double edged sword for companies because it is easy for other countries, such as India, to produce generic versions of the drug in bulk.

U.S. based companies hold rights to most of the world’s rights on new medicines and holds thousands of new products currently being developed. As of 2012, the industry helps support almost 3.4 million jobs in the U.S. economy. It is also one of the most heavily R&D based industries in the world. In the United States, the environment for pharmaceuticals is much friendlier than other countries around the world in terms of pricing ability and regulations. Both the Pharmaceutical and Biotechnology industries have experienced significant growth in the past year with year-over-year increases of 13.02% and 34.69% respectively. It is an even more striking when looking at the past five years considering both have beat out the S&P 500 with pharmaceuticals increasing an additional 31.44% and the biotechnology sector besting an astonishing 269.3% more return than the

In the video Escape Fire, I was so flabbergasted by the numbers and health outcomes we as a society have let our nation become. One of the most heart-wrenching evidence is, even though our health care industry is so expensive our health outcomes are the worse. 75% of disabilities and dead’s are preventable, according to the film.

The pharmaceutical industry continues to be a major driver of trend. While demand for medicine rapidly increases in emerging economies, a growing number of consumers are also analyzing the economic performance of different medicines. These events will heighten the challenges the

Even though there are many different challenges that will define strategic directions of the healthcare industry, five different challenges will be discussed within this paper. These challenges appear in all States and across the whole medical field from clinics, public hospitals, and private pharmaceutical companies. The selected challenges here will define what quality of services and terms that of the healthcare systems in the coming years. Because this involves several function variables, it is tough to know what to predict the progress of the systems within the health care industry.

Over the past four decades, spending on healthcare in the United States grew more rapidly than the economy (Baker, Birnbaum, Geppert, Mishol, Moyneur, 2008, p. 541). Healthcare has nearly tripled its share of national income during this time (p. 543). All aspects of the nation's health system have been affected by this ongoing spending growth. Strategically marketing the development of products and services during this intense competition and uncertainty is vital for any healthcare organization to stay profitable and to ensure continued growth.

The purpose of the film was to show how pharmaceuticals have effected Americans in a negative way. The United states represents five percent of the world’s population but consumes more than fifty percent of the world’s pharmaceuticals. This has caused 106,000 American’s to die from prescriptions drugs a year. People are becoming addicted to prescription drugs that doctors are writing a prescription for such as narcotics, opioids, and painkillers. These medicines are originally used to help with serious medical conditions but they are highly addictive. People start off with using the medication in a positive way, then end up taking them even after their medical condition is no longer there. That’s where we start to see an outrages number in

In this paper I will be responding to an article by Richard Anderson, business reporter for the BBC NEWS, titled “Pharmaceutical Industry Gets High On Fat Profits.” In Anderson’s article, the most interesting topics are how some drugs can really help and even save lives, how pharmaceutical companies have been accused of some corruptions, and how there is controversy surrounding profiting of drug companies. Overall, I learned a great deal from this article.

Currently, I am a Patient Services Coordinator in the healthcare industry. This industry often experiences Porter’s five forces: barriers to entry, bargaining power of suppliers, existing rivalry, bargaining power of buyers, and the threat of substitutes. The healthcare industry has many barriers to entry. The main barriers to entry in the healthcare industry include the huge capital requirements and adherence to the various policies developed by the government and other government agencies. Parnell (2004) note that government has set in place substantial regulatory requirements for healthcare organizations.

(Moynihan and Mintzes 2010, 2). Fox and Ward have illustrated their argument with examples to show that pharmaceutical companies are penetrating domestic lives through the internet, online consultations, and appeal to sensitive and embarrassing issues like obesity. To validate their research, the authors claim that other scholars have reached a similar expert consensus about domestic, internet drug influence.

Every year, almost one million Americans are diagnosed with some type of cancer. These people will undergo numerous examinations, testing, toxic medicines, cancer-causing radiation, and surgeries. These treatments continuously feed the multi-billion-dollar pharmaceutical and medical industry. With all the expensive treatments available, not many people are cured, just treated. What if there was a low-cost treatment program that cured cancer naturally? There are many licensed doctors in America doing just that and are being shunned by the medical community. They are called “quacks” by the Federal Drug Administration (FDA) and have become outlaws in their own country. The reason for pushing these doctors aside is simple; money. There is no big money in natural treatments and cures for cancer.

We analyzed the Indian Pharmaceutical industry on these five forces and the findings of industry competitiveness and profitability are written under the relevant competitive forces.

Yes, there is an impact on the pharmaceutical company, like those in the US as a result of differential prices between that country and other nations.

The report basically highlights on how the pharmaceutical industry of India works and its dynamics. The report also highlights about the Indian and global scenarios of pharmaceuticals industry and thereby comparison of those two. It comprises of analysing the industry by PEST, SWOT, PORTER’S five force model and HHI. It explains the current scenario of the industry in terms of growth and future outlook of the industry and opportunities.

This report provides an analytical strategic review of the global pharmaceutical industry; its origin, evolution,